| Total 939 Paclitaxel
related US patents (from
US Patent & Trademark Office)
No. 1
- 100 / 101-200
/ 201 - 300 / 301
- 400 / 401 - 500
/ 501 - 600 / 601
- 700 / 701 - 800
/ 801
- 900 / 901 -939
/
No. 901 - 939 Paclitaxel Patents:
|
PAT. NO. |
|
Title |
| 901 |
5,672,592 |
 |
Certain
phosphonomethyl-pentanedioic acid derivatives thereof |
| 902 |
5,670,663 |
|
Recovery
of taxanes from conifers |
| 903 |
5,670,658 |
|
Process
for preparing 7-trialkylsilyl baccatin III |
| 904 |
5,670,507 |
|
Method
for reversing multiple drug resistant phenotype |
| 905 |
5,667,809 |
|
Continuous
fluorochemical microdispersions for the delivery of lipophilic
pharmaceutical agents |
| 906 |
5,658,947 |
|
Method
and composition for selectively inhibiting melanoma using betalinic
acid |
| 907 |
5,656,651 |
|
Androgenic
directed compositions |
| 908 |
5,654,448 |
|
Isolation
and purification of paclitaxel from organic matter containing
paclitaxel, cephalomannine and other related taxanes |
| 909 |
5,654,328 |
|
Method
and composition for reducing tumor development with a combination of
platinum and tellurium or selenium compounds |
| 910 |
5,653,998 |
|
Injectable
liposomal pharmaceutical preparations |
| 911 |
5,652,248 |
|
Method
of preventing peripheral neuropathies induced by anticancer agents |
| 912 |
5,651,986 |
|
Controlled
local delivery of chemotherapeutic agents for treating solid tumors |
| 913 |
5,646,176 |
|
Phosphonooxymethyl
ethers of taxane derivatives |
| 914 |
5,635,531 |
|
3'-aminocarbonyloxy
paclitaxels |
| 915 |
5,626,862 |
|
Controlled
local delivery of chemotherapeutic agents for treating solid tumors |
| 916 |
5,622,986 |
|
2'-and/or
7-substituted taxanes |
| 917 |
5,620,875 |
|
Transfer
of taxol from yew tree cuttings into a culture medium over time |
| 918 |
5,616,330 |
|
Stable
oil-in-water emulsions incorporating a taxine (taxol) and method of
making same |
| 919 |
5,614,645 |
|
Methods
for making 2-debenzoyl and -2-acyl taxol derivatives |
| 920 |
5,614,549 |
|
High
molecular weight polymer-based prodrugs |
| 921 |
5,602,272 |
|
Reduction
and resolution methods for the preparation of compounds useful as
intemediates for preparing taxanes |
| 922 |
5,583,153 |
|
Use
of taxol in the treatment of rheumatoid arthritis |
| 923 |
5,580,899 |
|
Hydrophobic
taxane derivatives |
| 924 |
5,573,781 |
|
Methods
and compositions for the treatment of a host with a cellular
proliferative disease |
| 925 |
5,569,720 |
|
Polymer-bound
paclitaxel derivatives |
| 926 |
5,565,478 |
|
Combination
therapy using signal transduction inhibitors with paclitaxel and
other taxane analogs |
| 927 |
5,561,055 |
|
Bacterial
mass production of taxanes with Erwinia |
| 928 |
5,547,981 |
|
Taxol-7-carbazates |
| 929 |
5,543,152 |
|
Sphingosomes
for enhanced drug delivery |
| 930 |
5,534,499 |
|
Lipophilic
drug derivatives for use in liposomes |
| 931 |
5,504,102 |
|
Stabilized
pharmaceutical composition and stabilizing solvent |
| 932 |
5,489,589 |
|
Amino
acid derivatives of paclitaxel |
| 933 |
5,473,057 |
|
Eleutherobin
and analogs thereof |
| 934 |
5,473,055 |
|
Polymer-bound
paclitaxel derivatives |
| 935 |
5,468,769 |
|
Paclitaxel
derivatives |
| 936 |
5,395,850 |
|
6,7-epoxy
paclitaxels |
| 937 |
5,380,751 |
|
6,7-modified
paclitaxels |
| 938 |
5,362,831 |
|
Polymer-bound
paclitaxel derivatives |
| 939 |
5,324,739 |
|
Compound
exhibiting antiproliferative activity against cells |
No. 1
- 100 / 101-200
/ 201 - 300 / 301
- 400 / 401 - 500
/ 501 - 600 / 601
- 700 / 701 - 800
/ 801
- 900 / 901 -939
/
|
